diligently following central government orders and keeping their powder dry for the next wave of heavy spending on 6G mobile network infrastructure. China Telecom announced on Tuesday that its ...

Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with ...

This prospective study conducted in a phase 3 trial has shown that pre-treatment serum VEGF-A was a negative biomarker for PFS in patients with advanced NSCLC treated with a combination of an anti ...

In order to avoid the manifestation of PPR absorption and laser generation due to multiple random scattering, we used an optically thin layer of the laser dye (rhodamine 6G) solution doped with ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Fluorescence-based single-molecule and fluctuation spectroscopy in the near-IR can ...

The company also develops cellular technologies, such as technologies related to CDMA, TDMA, OFDM/OFDMA, and MIMO for use in 2G, 3G, 4G, and 5G wireless networks, as well as mobile terminal devices; ...

At close: March 27 at 4:00:01 PM EDT ...